FORMULATION AND EVALUATION OF AN INJECTABLE SOLUTION AS A DOSAGE FORM

  • Sneha Thomas Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India
  • S Mahendran Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India
  • R Selvakumar Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

Abstract

The present study will outline formulation and the evaluation methods of injectable dosage form. The various initial formulations of the developed and those are examined for drug release profile, bioavailability, and clinical effectiveness and for the pilot plant studies and production scale-up. The drug that we need should be most convenient and in proper form then only it reaches to the desired site of action. This is greatly influenced by which the type of dosage form of the drug. Since, injections include much variety of therapeutic agents. Injections are sterile, pyrogen limited, that is, bacterial endotoxin units limit, preparations intended to be administered parenterally. It is well recognized that the advantages of parenteral injections are immediate systemic drug availability and rapid onset of action.


Keywords: Injectable, Parenteral, Sterilization, Tonicity

Keywords: Injectable, Sterilization

Downloads

Download data is not yet available.

Author Biographies

Sneha Thomas, Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

S Mahendran, Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

R Selvakumar, Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

Department of Pharmaceutics, Nehru College of pharmacy, pampady, Thiruvillwamala, Thrissur, Kerala, India

References

1) Gary Evans and David Spadling. Handbook of Bioanalysis and Drug Metabolism.2004, Chapter 1, Bioanalysis, Pharmacokinetics and drug metabolism (BPDM). P. 1
2) Drug Approvals and Databases, U.S Department of Health and Human Services, [internet]. 2017 [Updated 2017 Nov 14].
Available from: - https://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm
3) Katdare A, Chaubal MV. Excipient development for pharmaceutical, biotechnology, and drug delivery systems. Taylor and Francis Group, LLC, 2006. Chapter 1; Regulation of pharmaceutical excipients. p. 37-38
4) Loyd V Allen, Jr., Nicholas G.popovich, Howard C. Ansel. Ansel’s Pharmaceutical dosage forms and drug delivery systems, 9th ed.Philadelphia: Lippincott Williams & Wilkins; 2011. Section II, Drug dosage form and drug delivery design, Chapter 4, Dosage form design: Pharmaceutical and formulation consideration. P.92
5) Dosage form designs [internet]. Available from : http://www.bspublications.net/downloads/05805bfacb3933_Ch-1_Pharmaceutical%20Dosage%20form_Kamlesh.pdf
6) Nagaraja Y.S., Nagaraja T.S., Bharathi D. R. and Manjunatha T. O. Formulation and evaluation of ofloxacin aqueous injection. IJPLS, 2012; 3(10):2015-2020
7) Venaktesawara Reddy B, Rasmitha Reddy B, Navaneetha K, Sampath Kumar V. A review on parenteral production technology. International journal of pharmacy and biological sciences. 2013; 3(1):596-610
8) Medical dictionary. The free dictionary by Farlex. [Internet]. 2013-2018. Available from: https://medical-dictionary.thefreedictionary.com/injection.
9) Gulati N, Gupta H. Parenteral drug delivery: a review. Recent patents on drug delivery & Formulation 2011, 5:133-145.
10) M.C. Allwood. Antimicrobial agents in single- and multi-dose Injections. Journal of Applied Bacteriology. 44(1), Svii- Sxvii. Willey online library.
11) Agrawal M, Limbachiya M, Sapariya A, Gatel G. A review on Prenteral controlled drug delivery system. International journal of Pharmaceutical Sciences and Research. P.3656-3669
12) Small volume parenterals. [Internet]. 2013-2018. Available from: https://pharmlabs.unc.edu/labs/parenterals/svp.htm
13) Large volume parenterals. [Internet]. Available from: http://pqri.org/wp-content/uploads/2015/11/Sacha.Characteristics_and_Requirements_for_Large_Volume_Parenterals.pdf
14) Joanne Broadhead, Pharmaceutical preformulation and formulation. Second edition. Volume 199, A practical guide from candidate drug selection to commercial dosage form, chapter 9: Parenteral dosage forms. P.332-350
15) Pramanick S, Sinodia D, Chandel V. Excipient selection in parenteral formulation development. Pharma Times. 2013; 45(3):65-75.
16) Michael J. Akers. Excipient- drug interactions in parenteral formulations. Journal of Pharmaceutical Sciences. 2002; 91(11):2283-2300.
17) Method used in the preparation of parenteral products. [Internet]. Available from: http://www.preservearticles.com/2011122319161/what-are-the-methods-used-in-the-preparation-of-parenteral-products.html
18) Linda A. Felton. Remington: Essentials of Pharmaceutics, Chapter 26, parenteral preparations. P. 497-530
19) General Pharmacology. Available from: file:///C:/Users/user/Downloads/Routes-of-adminstartion.pdf
20) What are the methods used in the preparation of parenteral products.[Internet]. Available from: http://www.preservearticles.com/2011122319161/what-are-the-methods-used-in-the-preparation-of-parenteral-products.html
21) Maquille A, Slegers C, Habib JL, Tilquin B. Electron beam and gamma radiolysis of solid-state metoclopramide. Pharm Res 2006; 23: 1343-1349.
22) Boyd C. E-beam sterilizes the industry. J Student Res 1.P. 39-43, 2002.
23) Marie- Noel Primeau MD, N.Franklin Adkinson Jr MD, Robert G. Hamilton PhD. Natural rubber Pharmaceutical vial closures release latex allergens that produce skin reactions. Journal of Allergy and Clinical Immunology. 2001; 107(6):958-962
24) pH from Wikipedia, the free encyclopedia. [Internet]. 2018[updated June 1] Available from: https://en.wikipedia.org/wiki/PH
25) Stephen E. Langille, Ph.D. Particulate matter in injectable drug. PDA journal of pharmaceutical Science and technology. 2018, July 7.p.1-17
26) FDA Guidelines 2004 “Guidance for Industry Sterile Drug Products by Aseptic processing, Current Good Manufacturing Practices,” September, 2004
27) ISO 11377 ANSI/AAMI/ISO 1137-2 1998-Sterilization of Medical Devices – Microbiological Methods- Part 2, Tests of sterility Performed in the Validation of a Sterilization Process
28) ISWO 11135 1994 Medical Devices Validation and Routine Control of Ethylene Oxide Sterilization
29) Code of Federal Regulations Title 21/Chapter 1/Part 820, “Quality systems Requirements: General ,” 2006
30) Guidance for Q1A (R2) stability testing of new drug substances and products under ICH guidelines
Statistics
89 Views | 189 Downloads
How to Cite
Thomas, S., Mahendran, S., & Selvakumar, R. (2018). FORMULATION AND EVALUATION OF AN INJECTABLE SOLUTION AS A DOSAGE FORM. Journal of Drug Delivery and Therapeutics, 8(5), 81-87. https://doi.org/10.22270/jddt.v8i5.1854